Drugs / \[68Ga\]-NOTA-hGZP
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04169321 | Jun 2020 → Mar 2025 | cancer, lymphoma | Cytosite Biopharma Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | \[68Ga\]-NOTA-hGZP | “\[68Ga\]-NOTA-hGZP is a PET imaging agent.” NCT04169321 ↗ |
| Modality | Diagnostic / imaging agent | “\[68Ga\]-NOTA-hGZP is a PET imaging agent.” NCT04169321 ↗ |